help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on December 13, 2007, doi:10.1164/rccm.200708-1233OC

Am. J. Respir. Crit. Care Med., Volume 177, Number 7, April 2008, 730-742

A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200708-1233OCv1
177/7/730    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Mall, M. A
Right arrow Articles by Boucher, R. C
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mall, M. A
Right arrow Articles by Boucher, R. C

Submitted on August 21, 2007
Accepted on December 13, 2007

Development of Chronic Bronchitis and Emphysema in {beta}ENaC Overexpressing Mice

Marcus A Mall1*, Jack R Harkema2, Joanna B Trojanek1, Diana Treis1, Alessandra Livraghi3, Susanne Schubert1, Zhe Zhou1, Silvia M Kreda3, Stephen L Tilley4, Elizabeth J Hudson3, Wanda K O'Neal3, and Richard C Boucher3

1 Department of Pediatrics III, University of Heidelberg, Pediatric Pulmonology and Cystic Fibrosis Center, Heidelberg, Germany, 2 Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, USA, 3 Cystic Fibrosis/Pulmonary Research and Treatment Center, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA, 4 Department of Medicine, Division of Pulmonary and Critical Care Medicine, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA

* To whom correspondence should be addressed. E-mail: Marcus.Mall{at}med.uni-heidelberg.de.

Rationale: Chronic obstructive pulmonary diseases are leading causes of death worldwide, but their pathogenesis is not well understood. Previous studies have shown that airway surface dehydration in {beta}ENaC overexpressing mice caused a chronic lung disease with high neonatal pulmonary mortality and chronic bronchitis in adult survivors. Objectives: The aim of this study was to identify the initiating lesions and investigate the natural progression of lung disease caused by airway surface dehydration. Methods: Lung morphology, gene expression, bronchoalveolar lavage and lung mechanics were studied at different ages in {beta}ENaC overexpressing mice. Measurements and Main Results: Mucus obstruction in {beta}ENaC overexpressing mice originated in the trachea in the first days of life and was associated with hypoxia, airway epithelial necrosis, and death. In surviving {beta}ENaC overexpressing mice, mucus obstruction extended into the lungs and was accompanied by goblet cell metaplasia, increased mucin expression, and airway inflammation with transient perinatal increases in TNF{alpha} and macrophages, IL-13 and eosinophils, and persistent increases in KC, neutrophils, and chitinases in the lung. {beta}ENaC overexpressing mice also developed emphysema with increased lung volumes, distal airspace enlargement, and increased lung compliance. Conclusions: Our studies demonstrate that airway surface dehydration is sufficient to initiate persistent neutrophilic airway inflammation with chronic airways mucus obstruction, and cause transient eosinophilic airway inflammation, and emphysema. These results suggest that deficient airway surface hydration may play a critical role in the pathogenesis of chronic obstructive pulmonary diseases of different etiologies and serve as a target for novel therapies.


Key words: Chronic obstructive lung disease; epithelial Na+ channels (ENaC); airway surface liquid (ASL); inflammation; mucus







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society